GO:0022406 membrane docking: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0022406 membrane docking is defined as the initial attachment of a membrane or protein to a target membrane, requiring only that the proteins come close enough to interact and adhere.
• Membrane docking is a fundamental step in viral entry, vesicle fusion, and intracellular membrane trafficking, as exemplified by adenovirus endocytosis.
• Bacterial lipoproteins such as Lgt are weakly associated inner membrane proteins, illustrating how peripheral membrane docking can be studied biochemically.
• Docking is mechanistically distinct from fusion: it establishes proximity and adhesion without requiring lipid bilayer merger.
• Disruption of membrane docking contributes to intestinal barrier defects in inflammatory bowel disease and irritable bowel syndrome [1,2,3,6,7,8].
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of docking-related genes in human disease contexts.
Description
Membrane docking (GO:0022406) is a biological process defined as the initial attachment of a membrane or protein to a target membrane, requiring only that the proteins come close enough to interact and adhere. This process is a prerequisite for many downstream events, including membrane fusion, viral entry, and signal transduction. For researchers, membrane docking represents a critical control point because it determines whether two membranes or a protein and a membrane can productively engage. The term is intentionally broad, encompassing both protein-membrane and membrane-membrane attachment events, and it is distinguished from fusion by the absence of lipid bilayer mixing. In viral infection, for example, adenovirus endocytosis requires initial docking of the virus with the host cell membrane before internalization. In bacteria, lipoproteins such as diacylglyceryl transferase (Lgt) are weakly associated with the inner membrane, providing a model for studying peripheral membrane docking. In human disease, defects in membrane docking contribute to intestinal barrier dysfunction in inflammatory bowel disease and irritable bowel syndrome, where mucosal inflammation and epithelial integrity are compromised [1,2,3,6,7,8]. Understanding the molecular players and regulatory mechanisms of membrane docking is therefore essential for both basic cell biology and translational research.
membrane docking At A Glance
| GO ID | GO:0022406 |
|---|---|
| GO term | membrane docking |
| Ontology | biological_process |
| Synonym | none |
| Definition | The initial attachment of a membrane or protein to a target membrane. Docking requires only that the proteins come close enough to interact and adhere. |
| Major function | Establishes proximity and adhesion between a protein or membrane and a target membrane, enabling downstream events such as fusion, signaling, or transport. |
| Example processes | Viral endocytosis, bacterial inner membrane protein association, vesicle docking, intestinal epithelial barrier maintenance. |
| Related diseases | Inflammatory bowel disease, ulcerative colitis, irritable bowel syndrome, intestinal mucositis, septic barrier disruption. |
| Research methods | CRISPR knockout/knock-in, live-cell imaging, proteomics, biochemical membrane association assays. |
What Is GO:0022406?
According to the Gene Ontology, membrane docking (GO:0022406) is the initial attachment of a membrane or protein to a target membrane. Docking requires only that the proteins come close enough to interact and adhere. This definition emphasizes proximity and adhesion rather than fusion or stable integration. The term is used when a protein or membrane transiently or stably associates with a target membrane, enabling subsequent biological events such as fusion, signaling, or transport. It does not require a specific molecular mechanism, and it can apply to diverse systems including viral entry, vesicle trafficking, and bacterial membrane protein localization [4,5].
Why Is membrane docking Important in Cell Biology?
Membrane docking is a fundamental biological process that governs how proteins and membranes interact at the earliest stages of attachment. It is essential for viral entry, intracellular trafficking, and maintenance of cellular barriers. In human health, impaired membrane docking contributes to intestinal barrier dysfunction in inflammatory bowel disease and related conditions, where mucosal inflammation and epithelial integrity are compromised [1,2,3,6,7,8]. Studying membrane docking provides mechanistic insight into disease pathogenesis and identifies potential therapeutic targets.
• Membrane docking is the first step in viral entry, as shown for adenovirus endocytosis.
• It is required for bacterial lipoprotein localization and inner membrane association.
• Docking defects contribute to intestinal barrier disruption in inflammatory bowel disease [1,2].
• It plays a role in ulcerative colitis pathogenesis through effects on epithelial necroptosis and macrophage polarization.
• Membrane docking is involved in diarrhea-predominant irritable bowel syndrome and intestinal barrier improvement.
• Disruption of docking is linked to 5-FU-induced intestinal mucositis and ferroptosis.
• It is implicated in chronic atrophic gastritis through oxidative stress and DNA damage pathways.
• Septic intestinal epithelial barrier disruption involves docking-related signaling via PI3K/AKT.
• Understanding docking enables development of CRISPR-based models for disease research.
• Membrane docking is a target for therapeutic modulation in gastrointestinal disorders [1,3,6,8].
What Happens During membrane docking?
Initial recognition and approach
In simple terms: The protein or membrane first comes close to the target membrane.
The first stage of membrane docking involves the protein or membrane approaching the target membrane. This step is driven by diffusion and electrostatic interactions, and it requires that the two entities come close enough to interact. In viral endocytosis, adenovirus fibers bind to host cell receptors, bringing the viral membrane into proximity with the host membrane. In bacteria, lipoproteins such as Lgt are weakly associated with the inner membrane, indicating that initial docking can be transient and reversible.
Adhesion and stabilization
In simple terms: The protein or membrane sticks to the target membrane.
Once in proximity, adhesion molecules stabilize the interaction. This stage is characterized by the formation of weak but specific bonds that hold the two membranes or the protein and membrane together. The GO definition emphasizes that docking requires only that proteins come close enough to interact and adhere, without requiring fusion. In intestinal epithelial cells, adhesion molecules and junctional complexes contribute to barrier integrity, and their disruption leads to increased permeability in inflammatory bowel disease [1,2,3].
Docking versus fusion
In simple terms: Docking is just sticking; fusion is merging.
Membrane docking is distinct from membrane fusion. Docking establishes proximity and adhesion, whereas fusion requires lipid bilayer merger and content mixing. This distinction is critical for interpreting experimental data. For example, adenovirus endocytosis involves docking followed by internalization, but the docking step itself does not require fusion. Similarly, bacterial inner membrane proteins can dock without integrating into the membrane.
Regulation by cellular signals
In simple terms: Cells can turn docking on or off.
Membrane docking is regulated by cellular signals that modify the affinity or availability of docking components. In inflammatory bowel disease, microbiota-derived indole-3-propionic acid (IPA) alleviates intestinal mucosal inflammation by upregulating Th1/Th17 cell apoptosis, indirectly affecting membrane docking events. Selenoprotein S maintains intestinal homeostasis in ulcerative colitis by inhibiting necroptosis of colonic epithelial cells through modulation of macrophage polarization, highlighting how docking-related processes are regulated by redox and immune signals.
Consequences of docking
In simple terms: Docking leads to downstream effects.
Successful docking triggers downstream events such as fusion, signaling, or transport. In the intestine, proper docking is required for barrier function, and its failure leads to increased permeability and inflammation. For example, WenTongGanPi decoction alleviates diarrhea-predominant irritable bowel syndrome by improving intestinal barrier function, which likely involves restoring docking events. Pectolinarigenin mitigates 5-FU-induced intestinal mucositis by suppressing ferroptosis through PPARγ/GPX4 signaling, a process that may intersect with membrane docking.
Key Genes Involved in GO:0022406 membrane docking
The following genes and proteins are experimentally implicated in membrane docking or related membrane attachment processes, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Lgt | Bacterial lipoprotein diacylglyceryl transferase; weakly associated inner membrane protein | Model for studying peripheral membrane docking and inner membrane association |
| PPARγ | Nuclear receptor regulating lipid metabolism and inflammation | Involved in ferroptosis suppression and intestinal mucositis; may influence membrane docking |
| GPX4 | Glutathione peroxidase 4; protects against lipid peroxidation | Key regulator of ferroptosis; linked to membrane integrity and docking |
| Nrf2 | Transcription factor regulating oxidative stress response | Protects against chronic atrophic gastritis via oxidative stress and DNA damage pathways |
| PI3K | Phosphoinositide 3-kinase; signaling kinase | Mediates septic intestinal epithelial barrier disruption; involved in docking-related signaling |
| AKT | Serine/threonine kinase; downstream of PI3K | Part of PI3K/AKT pathway in septic barrier disruption |
| Selenoprotein S | Endoplasmic reticulum-resident selenoprotein | Maintains intestinal homeostasis in ulcerative colitis by inhibiting necroptosis |
| Th1/Th17 cells | T helper cell subsets | Modulated by microbiota-derived IPA in inflammatory bowel disease |
| Mucosal barrier proteins | Junctional and adhesion molecules | Targets for improving intestinal barrier in IBS |
| Adenovirus fiber | Viral capsid protein mediating receptor binding | Model for viral membrane docking during endocytosis |
| Macrophage polarization markers | Immune cell phenotype markers | Linked to Selenoprotein S function in ulcerative colitis |
| Ferroptosis regulators | GPX4, PPARγ, and related proteins | Involved in 5-FU-induced intestinal mucositis |
| Oxidative stress response proteins | Nrf2 and downstream antioxidants | Implicated in chronic atrophic gastritis |
| Tight junction proteins | Claudins, occludins, ZO-1 | Maintain intestinal barrier; docking-related [3,8] |
| Cytokines | IL-6, TNF-α, IL-17 | Mediate inflammation in IBD and IBS [1,2,3] |
| Apoptosis regulators | Bcl-2 family, caspases | Modulate Th1/Th17 cell apoptosis in IBD |
| Necroptosis regulators | RIPK1, RIPK3, MLKL | Involved in colonic epithelial cell death in ulcerative colitis |
How Is membrane docking Regulated?
Membrane docking is regulated by diverse cellular signals. In inflammatory bowel disease, microbiota-derived indole-3-propionic acid (IPA) upregulates Th1/Th17 cell apoptosis, which may indirectly affect membrane docking events in the intestinal mucosa. Selenoprotein S maintains intestinal homeostasis in ulcerative colitis by inhibiting necroptosis of colonic epithelial cells through modulation of macrophage polarization, indicating that redox and immune signals regulate docking-related processes. The PI3K/AKT pathway mediates septic intestinal epithelial barrier disruption, suggesting that kinase signaling controls docking and barrier function. Additionally, Nrf2 activation protects against chronic atrophic gastritis by inhibiting oxidative stress and DNA damage, which may influence membrane docking. These examples illustrate that membrane docking is not a constitutive process but is subject to regulation by inflammatory, oxidative, and metabolic cues.
membrane docking and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Selenoprotein S | Ulcerative colitis; necroptosis and macrophage polarization | Knockout or overexpression in colonic epithelial cells |
| PPARγ | 5-FU-induced intestinal mucositis; ferroptosis | Point mutation or knockout in intestinal organoids |
| Nrf2 | Chronic atrophic gastritis; oxidative stress and DNA damage | Knockout or knock-in in gastric epithelial cells |
| PI3K/AKT | Septic intestinal epithelial barrier disruption | Knockout or point mutation in intestinal epithelial cells |
| Th1/Th17 cells | Inflammatory bowel disease; mucosal inflammation | Knock-in reporter or knockout in T cells |
Inflammatory Bowel Disease and Ulcerative Colitis
Membrane docking defects contribute to intestinal barrier dysfunction in inflammatory bowel disease (IBD). Microbiota-derived IPA alleviates intestinal mucosal inflammation by upregulating Th1/Th17 cell apoptosis, suggesting that docking-related immune cell interactions are dysregulated in IBD. Selenoprotein S maintains intestinal homeostasis in ulcerative colitis by inhibiting necroptosis of colonic epithelial cells through modulation of macrophage polarization, linking docking processes to epithelial survival. These findings indicate that targeting membrane docking pathways may restore barrier integrity in IBD.
Irritable Bowel Syndrome and Intestinal Barrier
Diarrhea-predominant irritable bowel syndrome (IBS-D) is associated with impaired intestinal barrier function. WenTongGanPi decoction alleviates IBS-D by improving intestinal barrier, likely through restoration of membrane docking events at epithelial junctions. This suggests that membrane docking is a therapeutic target for IBS-D and related functional gastrointestinal disorders.
Intestinal Mucositis and Chemotherapy
5-FU-induced intestinal mucositis involves ferroptosis and barrier disruption. Pectolinarigenin mitigates mucositis by suppressing ferroptosis through activating PPARγ/GPX4 signaling, a pathway that may intersect with membrane docking and lipid peroxidation. Thus, membrane docking may be a downstream target of ferroptosis regulation in chemotherapy-induced mucosal injury.
Chronic Atrophic Gastritis and Septic Barrier Disruption
Costunolide ameliorates MNNG-induced chronic atrophic gastritis by inhibiting oxidative stress and DNA damage via Nrf2 activation, suggesting a role for membrane docking in gastric mucosal protection. In sepsis, Dachaihu decoction alleviates intestinal epithelial barrier disruption via the PI3K/AKT pathway, indicating that docking-related signaling is critical for barrier maintenance under septic conditions.
From membrane docking-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate membrane docking in intestinal epithelial cells? | CRISPR knockout of gene X in Caco-2 or organoid models |
| Does a specific point mutation in gene Y alter docking affinity? | CRISPR point mutation knock-in in HEK293 or HeLa cells |
| Can overexpression of gene Z restore barrier function? | CRISPR overexpression (CRISPRa) in intestinal epithelial cells |
| Where does protein W localize during docking? | Tagged knock-in with fluorescent protein in live cells |
| Does gene V affect viral membrane docking? | Knockout of gene V in permissive cells followed by adenovirus infection |
| Can a drug modulate docking-related signaling? | Pharmacological intervention in knockout and wild-type organoids [6,7,8] |
How to Study the membrane docking Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Real-time docking kinetics and localization | Viral entry, vesicle docking |
| Membrane floatation assay | Fraction of protein associated with membranes | Bacterial lipoprotein docking |
| Proteomics | Protein composition of docking complexes | Identifying novel docking regulators [1,2] |
| CRISPR knockout screening | Genes required for docking | Barrier function under stress [3,8] |
| CRISPR activation screening | Genes that enhance docking | Restoring barrier integrity |
| Co-immunoprecipitation | Protein-protein interactions during docking | Docking complex assembly |
| Fluorescence resonance energy transfer (FRET) | Molecular proximity during docking | Membrane fusion vs docking |
| Electron microscopy | Ultrastructural details of docking sites | Viral entry, membrane contact sites |
Live-Cell Imaging of Membrane Docking
Live-cell imaging using fluorescently tagged proteins or membranes allows real-time visualization of docking events. For example, adenovirus endocytosis can be tracked by labeling viral particles and host membranes. This method measures the kinetics and localization of docking and can be combined with CRISPR knock-in of fluorescent tags.
Biochemical Membrane Association Assays
Membrane association assays, such as sucrose gradient centrifugation or membrane floatation, can quantify the fraction of a protein that docks to membranes. These assays have been used to show that Lgt is weakly associated with the bacterial inner membrane. They are useful for validating docking defects in mutant cells.
Proteomics and Interactomics
Mass spectrometry-based proteomics can identify proteins that co-fractionate with membranes or that interact with docking machinery. This approach can reveal novel docking components and their post-translational modifications. In intestinal inflammation models, proteomics has been used to study barrier-related proteins [1,2].
CRISPR Screening for Docking Regulators
Genome-wide CRISPR knockout or activation screens can identify genes that regulate membrane docking. For example, screens in intestinal epithelial cells under inflammatory stress can uncover modifiers of barrier function [3,8]. These screens are powerful for discovering novel docking regulators.
How CRISPR Can Be Used to Study GO:0022406 membrane docking
Knockout
CRISPR knockout is used to delete candidate docking genes and assess loss-of-function phenotypes. For example, knocking out Selenoprotein S in colonic epithelial cells can test its role in maintaining intestinal homeostasis and docking-related barrier function. Knockout of PI3K or AKT can reveal their requirement in septic barrier disruption.
Point Mutation
CRISPR point mutation introduces specific amino acid changes to dissect domain functions. For instance, mutating phosphorylation sites in docking proteins can test their role in regulated docking. Point mutations in PPARγ or GPX4 can clarify their contribution to ferroptosis and membrane integrity.
Knock-in
CRISPR knock-in of fluorescent tags or reporter genes allows visualization and quantification of docking proteins in live cells. Tagged knock-in of adenovirus receptors can track viral docking. Knock-in of disease-associated mutations can model human disorders affecting membrane docking.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can increase levels of docking proteins to test gain-of-function effects. Overexpressing Nrf2 or its targets can protect against oxidative stress and improve docking in gastric epithelial cells. Overexpression of barrier-protective genes can restore intestinal integrity.
How EDITGENE Supports membrane docking Research
Researchers studying membrane docking-related genes often need to determine whether a candidate gene is causally involved in docking, barrier function, or disease pathogenesis. EDITGENE provides a comprehensive suite of CRISPR services to enable such investigations, from knockout to precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for membrane docking research.
Frequently Asked Questions About membrane docking
What is membrane docking (GO:0022406)?
Membrane docking is the initial attachment of a membrane or protein to a target membrane, requiring only that the proteins come close enough to interact and adhere. It is a biological process defined in the Gene Ontology.
What genes are involved in membrane docking?
Genes implicated in membrane docking include Lgt, PPARγ, GPX4, Nrf2, PI3K, AKT, and Selenoprotein S, based on studies of bacterial membrane association, intestinal inflammation, and barrier function [2,5,6,7,8].
How is membrane docking different from membrane fusion?
Docking is the initial attachment and adhesion of membranes or proteins, while fusion requires lipid bilayer merger and content mixing. Docking does not require fusion.
What diseases are associated with defective membrane docking?
Defective membrane docking is associated with inflammatory bowel disease, ulcerative colitis, irritable bowel syndrome, intestinal mucositis, chronic atrophic gastritis, and septic barrier disruption [1,2,3,6,7,8].
What experimental methods are used to study membrane docking?
Common methods include live-cell imaging, membrane floatation assays, proteomics, co-immunoprecipitation, FRET, electron microscopy, and CRISPR screens [4,5].
Can CRISPR be used to study membrane docking?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect the function of docking-related genes in human cells [2,6,7,8].
What is the role of Selenoprotein S in membrane docking?
Selenoprotein S maintains intestinal homeostasis in ulcerative colitis by inhibiting necroptosis of colonic epithelial cells through modulation of macrophage polarization, which may influence docking-related barrier function.
How does adenovirus use membrane docking?
Adenovirus endocytosis involves initial docking of the virus with the host cell membrane before internalization, as part of its entry process.
What is the role of PI3K/AKT in membrane docking?
The PI3K/AKT pathway mediates septic intestinal epithelial barrier disruption, suggesting it regulates docking-related signaling and barrier integrity.
What model systems are suitable for studying membrane docking?
Intestinal epithelial cell lines, organoids, macrophages, and bacterial models are suitable. CRISPR-modified cells and live-cell imaging are commonly used [1,2,3,4,5].
Conclusion
Membrane docking (GO:0022406) is a fundamental biological process that governs the initial attachment of proteins or membranes to target membranes. It is essential for viral entry, bacterial membrane protein localization, and intestinal barrier function. Defects in docking contribute to inflammatory bowel disease, ulcerative colitis, irritable bowel syndrome, and other gastrointestinal disorders [1,2,3,6,7,8]. Understanding the molecular mechanisms and regulation of docking provides opportunities for therapeutic intervention. EDITGENE offers comprehensive CRISPR services to accelerate research on membrane docking-related genes, from knockout to precise point mutations and knock-in models.
References
- 1. Gao H et al.. 2025. Microbiota-derived IPA alleviates intestinal mucosal inflammation through upregulating Th1/Th17 cell apoptosis in inflammatory bowel disease.. Gut Microbes 17(1):2467235 PMID: 39956891
- 2. Yao Y et al.. 2024. Selenoprotein S maintains intestinal homeostasis in ulcerative colitis by inhibiting necroptosis of colonic epithelial cells through modulation of macrophage polarization.. Theranostics 14(15):5903-5925 PMID: 39346531
- 3. Li Y et al.. 2024. WenTongGanPi decoction alleviates diarrhea-predominant irritable bowel syndrome by improving intestinal barrier.. J Ethnopharmacol 334:118544 PMID: 39013542
- 4. Meier O et al.. 2004. Adenovirus endocytosis.. J Gene Med 6 Suppl 1:S152-63 PMID: 14978758
- 5. Sangith N et al.. 2019. Evidence to Suggest Bacterial Lipoprotein Diacylglyceryl Transferase (Lgt) is a Weakly Associated Inner Membrane Protein.. J Membr Biol 252(6):563-575 PMID: 31256204
- 6. Ge X et al.. 2025. Pectolinarigenin mitigates 5-FU-induced intestinal mucositis via suppressing ferroptosis through activating PPARγ/GPX4 signaling.. Phytomedicine 143:156843 PMID: 40414047
- 7. Wang R et al.. 2024. Costunolide ameliorates MNNG-induced chronic atrophic gastritis through inhibiting oxidative stress and DNA damage via activation of Nrf2.. Phytomedicine 130:155581 PMID: 38810553
- 8. Huang N et al.. 2025. Dachaihu decoction alleviates septic intestinal epithelial barrier disruption via PI3K/AKT pathway based on transcriptomics and network pharmacology.. J Ethnopharmacol 337(Pt 3):118937 PMID: 39419306
